Hikal Limited

Drug Manufacturers-Specialty & Generic

Prices are adjusted according to historical splits.

Hikal Limited Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
₹35.13 billion
Book Value:
Revenue TTM:
₹19.80 billion
Operating Margin TTM:
Gross Profit TTM:
₹9.00 billion
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Hikal Limited had its IPO on under the ticker symbol HIKAL.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Hikal Limited has a staff strength of 1,906 employees.

Stock update

Shares of Hikal Limited opened at ₹288 at the start of the last trading session i.e. 2023-05-28.

The stocks traded within a range of ₹283.05 - ₹292.2, and closed at ₹284.

This is a -1.2% slip from the previous day's closing price.

A total volume of 321,439 shares were traded at the close of the day’s session.

In the last one week, shares of Hikal Limited have slipped by -4.38%.

Hikal Limited's Key Ratios

Hikal Limited has a market cap of ₹35.13 billion, indicating a price to book ratio of 4.4328 and a price to sales ratio of 2.4413.

In the last 12-months Hikal Limited’s revenue was ₹19.80 billion with a gross profit of ₹9.00 billion and an EBITDA of ₹2.29 billion. The EBITDA ratio measures Hikal Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Hikal Limited’s operating margin was 6.45% while its return on assets stood at 0% with a return of equity of 781.83%.

In Q4, Hikal Limited’s quarterly earnings growth was a negative -41.7% while revenue growth was a positive 5%.

Hikal Limited’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at ₹5.13 per share while it has a forward price to earnings multiple of 18.797 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Hikal Limited’s profitability.

Hikal Limited stock is trading at a EV to sales ratio of 2.7544 and a EV to EBITDA ratio of 21.6137. Its price to sales ratio in the trailing 12-months stood at 2.4413.

Hikal Limited stock pays annual dividends of ₹1 per share, indicating a yield of 0.35% and a payout ratio of 29.09%.

Balance sheet and cash flow metrics

Total Assets
₹23.19 billion
Total Liabilities
₹8.12 billion
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

Hikal Limited ended 2023 with ₹23.19 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹23.19 billion while shareholder equity stood at ₹10.80 billion.

Hikal Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹8.12 billion in other current liabilities, 246600000.00 in common stock, ₹10.55 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹114.40 million and cash and short-term investments were ₹657.30 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹3.38 billion.

Hikal Limited’s total current assets stands at ₹9.86 billion while long-term investments were ₹0 and short-term investments were ₹150.60 million. Its net receivables were ₹4.89 billion compared to accounts payable of ₹2.49 billion and inventory worth ₹3.34 billion.

In 2023, Hikal Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Hikal Limited paid ₹0.29 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Hikal Limited stock is currently trading at ₹284 per share. It touched a 52-week high of ₹427.1705 and a 52-week low of ₹427.1705. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹293.9 and 200-day moving average was ₹328.13 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6904.4% of the company’s stock are held by insiders while 622.3% are held by institutions.

Frequently Asked Questions About Hikal Limited

The stock symbol (also called stock or share ticker) of Hikal Limited is HIKAL

The IPO of Hikal Limited took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price

Most Active

Last Price
Tesla Inc (TSLA)

Top Gainers

Last Price
Boxed Inc (BOXD)

Top Losers

Last Price


Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.